A phase II evaluation of pembrolizumab in recurrent microsatellite instability-high (MSI-H) endometrial cancer patients with Lynch-like versus MLH-1 methylated characteristics (NCT02899793)
一项针对复发性微卫星不稳定性高（MSI-H）子宫内膜癌患者（具有林奇样特征与MLH-1甲基化特征）的帕博利珠单抗II期评估（NCT02899793）
期刊:Annals of Oncology
影响因子:65.4
doi:10.1016/j.annonc.2021.04.013
Bellone, S; Roque, D M; Siegel, E R; Buza, N; Hui, P; Bonazzoli, E; Guglielmi, A; Zammataro, L; Nagarkatti, N; Zaidi, S; Lee, J; Silasi, D-A; Huang, G S; Andikyan, V; Damast, S; Clark, M; Azodi, M; Schwartz, P E; Tymon-Rosario, J; Harold, J; Mauricio, D; Zeybek, B; Menderes, G; Altwerger, G; Ratner, E; Alexandrov, L B; Iwasaki, A; Kong, Y; Song, E; Dong, W; Elvin, J; Choi, J; Santin, A D
